Company: SYRA
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-022023
Chunk: 20

Company: Syra Health Corp
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 1
Chunk 20
---
the period. For the periods presented, potential dilutive securities had an anti-dilutive effect and were not included in the calculation
of diluted net loss per common share.

Common
shares consisting of shares potentially dilutive that are excluded from the calculated of diluted earnings per share because they are
anti-dilutive as of September 30, 2025 and 2024 are as follows:

 Schedule of Diluted Earnings Per Share

    September
30, 2025  
    September
30, 2024 
  
    Warrants 
     8,172,842  
     8,195,967 
  
    Stock options 
     296,245  
     150,250 
  
    Total 
     8,469,087  
     8,346,217 

Note
5 – Other Current Assets

Other
current assets included the following as of September 30, 2025 and December 31, 2024:

 Schedule of Other Current Assets

    September 30, 2025  
    December 31, 2024 

    Prepaid expenses and other current assets 
     307,791  
     276,563 
  
    Total other current assets 
    $307,791  
    $276,563 

Note
6 – Property and Equipment

Property
and equipment at September 30, 2025 and December 31, 2024, consisted of the following:

 Schedule of Property and Equipment

    September 30, 2025  
    December 31, 2024 
  
    Office equipment – 5 year estimated life 
    $86,958  
    $86,958 
  
    Leasehold improvements – 2 year estimated life 
     60,783  
     60,783 
  
    Furniture and fixtures – 7 year estimated life 
     6,170  
     6,170 
  
    Property and equipment, gross
 
     6,170  
     6,170 

    Less: Accumulated depreciation 
     (144,735) 
     (126,564)
  
    Total property and equipment, net 
    $9,176  
    $27,347 

Depreciation
of property and equipment was $18,171 and $55,460 for the nine months ended September 30, 2025 and 2024, respectively